日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Axl Regulation of NK Cell Activity Creates an Immunosuppressive Tumor Immune Microenvironment in Head and Neck Cancer.

Axl 对 NK 细胞活性的调节在头颈癌中创造了免疫抑制性肿瘤免疫微环境

Kostecki Kourtney L, Harmon Regan L, Iida Mari, Harris Madelyn A, Crossman Bridget E, Bruce Justine Yang, Salgia Ravi, Wheeler Deric L

Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit

头颈癌的免疫逃逸策略:逃避、抵抗、抑制、招募

Kostecki, Kourtney L; Iida, Mari; Crossman, Bridget E; Salgia, Ravi; Harari, Paul M; Bruce, Justine Y; Wheeler, Deric L

From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma

从实验室到临床:团队采用多学科策略对抗头颈部鳞状细胞癌的治疗耐药性

Crossman, Bridget E; Harmon, Regan L; Kostecki, Kourtney L; McDaniel, Nellie K; Iida, Mari; Corday, Luke W; Glitchev, Christine E; Crow, Madisen T; Harris, Madelyn A; Lin, Candie Y; Adams, Jillian M; Longhurst, Colin A; Nickel, Kwangok P; Ong, Irene M; Alexandridis, Roxana A; Yu, Menggang; Yang, David T; Hu, Rong; Morris, Zachary S; Hartig, Gregory K; Glazer, Tiffany A; Ramisetty, Sravani; Kulkarni, Prakash; Salgia, Ravi; Kimple, Randall J; Bruce, Justine Y; Harari, Paul M; Wheeler, Deric L

ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201.

局部用 Jak1/3 抑制剂 ATI-1777 可能在不进行全身用药的情况下使特应性皮炎受益:临床前开发和 2a 期随机对照研究 ATI-1777-AD-201 的结果

Changelian Paul, Xu Canxin, Mnich Steve, Hope Heidi, Kostecki Kourtney, Hirsch Jeff, Loh Chin-Yi, Anderson David, Blinn James, Hockerman Susan, Dick Evan, Smith Walter, Monahan Joseph, Raoof Tooraj, Forman Seth, Burt David, Barnes Brad, Gordon David, Walker Neal, Sudzina John, Tucker Stephen, Jacobsen Jon